Table VII.

Early (0–30 days) and late (31–365 days) major adverse events (MAE)

System	0–30 days (early)	31–365 days (late)	0–365 days
	% (n/N)	% (n/N)	% (n/N)
Patients with ≥1 MAE	11.1 (36/323)	5.4 (17/314)	15.5 (50/323)
Death	2.8 (9/323)	3.8 (12/314)	6.5 (21/323)
Myocardial infarction	4.0 (13/323)	2.2 (7/314)	6.2 (20/323)
Cerebrovascular accident	1.5 (5/323)	0.6 (2/314)	2.2 (7/323)
Renal failure	2.5 (8/323)	0.0 (0/314)	2.5 (8/323)
Respiratory failure	4.3 (14/323)	0.3 (1/314)	4.6 (15/323)
Paralysis/paraparesis	0.3 (1/323)	0.0 (0/314)	0.3 (1/323)
Bowel ischemia	6.2 (2/323)	0.3 (1/314)	0.6 (2/323)